Robertson, M J, Schacterle, R S, Mackin, G A et al. · Clinical and experimental immunology · 2005 · DOI
This study looked at immune cells in the blood of people with ME/CFS and compared them to people with depression, multiple sclerosis, and healthy individuals. While the total numbers of major immune cell types were similar across groups, researchers found differences in specific subtypes of these cells, particularly in natural killer cells. This suggests that ME/CFS may involve changes in how the immune system is organized, even if total cell counts appear normal.
This study provides objective immunological markers that distinguish ME/CFS from other conditions like depression and MS, which is clinically important given diagnostic confusion. Identification of specific immune cell subset abnormalities supports the biological basis of ME/CFS and may guide future therapeutic targets.
This study does not prove that lymphocyte subset alterations cause ME/CFS symptoms, only that differences exist. Cross-sectional design means temporal relationships cannot be established—these changes may be consequences rather than causes of the disease. The study also does not determine whether these immune differences are functionally relevant or clinically meaningful.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →